Biosafety Program

IMPACT OF COVID-19 ON THE BIOSAFETY PROGRAM

All campus laboratory experiments are suspended effective March 23, 2020. If there is a need to continue on-campus research activities during limited campus operations, a plan to manage these laboratory activities with minimal staffing must be developed, submitted and approved by your Department Chair and Dean and the Return to Research Committee. Any continued activities must limit personnel and follow social distancing requirements issued by the State of Oregon.

Please visit the RGS website for the most up-to-date information related to COVID-19 impacts on research at PSU.

Portland State University’s Biosafety Program and the Institutional Biosafety Committee (IBC) oversee research activities involving recombinant DNA and potentially bio-hazardous materials in order to assure compliance with regulatory requirements and conformance to best practices. The IBC is an ethics review committee required by the NIH and at PSU is responsible for reviewing and approving all related biosafety research.

Biosafety Approval & Oversight

To request approval for a proposed research study involving recombinant DNA or other potentially biohazardous materials, investigators must submit a protocol application for review by the IBC. A complete IBC submission includes a completed Biosafety Protocol Application and an appropriate Biosafety Manual. Review typically takes between 2-4 weeks and requires a lab assessment performed by the Biosafety Officer. The protocol application and biosafety templates are provided below. Completed form(s) must be submitted by email to ibc@pdx.edu. Once approved, biosafety protocols are generally approved for three years, with an annual lab assessment performed by the Biosafety Program.

Applications & Forms

Biosafety Manual Templates

Biosafety Training

Faculty, staff and students conducting regulated biosafety research are required to complete the Biosafety research training available via the Collaborative Institutional Training Initiative (CITI). All listed personnel must complete Biosafety CITI training prior to protocol approval (CITI training must be completed within the last three years).

Visit our Training page for specific biosafety training login and completion instructions.

Institutional Biosafety Committee Meetings

The Institutional Biosafety Committee meets approximately once a month. Meetings are subject to re-scheduling due to holidays, university closures, no meeting quorum, etc. At this time, all IBC meetings are hosted virtually, using an online meeting platform. Meetings are scheduled on an as-needed basis.

  • This site is updated with a meeting agenda at least one week in advance of a scheduled meeting. The next IBC meeting is scheduled for:

      • No meetings scheduled at this time

  • To confirm upcoming meeting information, please contact the Biosafety Program at ibc@pdx.edu.

Contact Us

For additional questions related to the use of recombinant DNA and potentially bio-hazardous materials, please contact the Biosafety Program at ibc@pdx.edu or (503) 725-9814.